Thursday, 4 August 2022
FORESFA and VIE project meetings
The Medicine Quality Research Group organised a multidisciplinary hybrid meeting at Keble College, Oxford, July 3 to 6, for the FORESFA project ‘Forensic epidemiology and impact of substandard and falsified antimicrobials on public health’, funded by a Wellcome Collaborative Award.
Wednesday, 20 July 2022
Incomplete reporting of COVID-19 disease severity criteria compromises meta-analysis
Patients affected by COVID-19 should be treated according to the severity of their disease. However, new research out today finds that not all key national or international organisations define severity in the same way.
Thursday, 23 June 2022
Field evaluation of EasyScan GO: a digital malaria microscopy device
Microscopic examination of Giemsa-stained blood films is key to quantifying and detecting malaria parasites but there can be difficulties in ensuring both a high-quality manual reading and inter-reader reliability. The EasyScan GO was developed as a potential solution to this, a microscopy device us...
Friday, 6 May 2022
Experts emphasise the importance of cooperation in sharing data on artemisinin resistance in Africa
Drug-resistant malaria is now a critical public health emergency on a global scale. In a new editorial a diverse group of malaria researchers, including WWARN senior scientists, have highlighted that the artemisinin confirmed recently in Rwanda and Uganda is likely just the ‘tip of the spear’, with ...
Tuesday, 29 March 2022
Indian authorities sign an MoU for a data and skill-sharing partnership between ICMR and IDDO
The Indian government’s Union Cabinet, chaired by Prime Minister Shri Narendra Modi, has approved a Memorandum of Understanding (MoU) between the Indian Council of Medical Research (ICMR) and the Infectious Diseases Data Observatory (IDDO), based at the University of Oxford.
Monday, 28 March 2022
Artemisinin combination therapy trials need longer follow-up to detect late treatment failures for Plasmodium falciparum malaria
WWARN researchers have been assessing the recommended minimum follow-up period in capturing polymerase chain reaction (PCR)-confirmed recrudescence following treatment with fixed-dose artemisinin combination therapies (ACTs) for patients with uncomplicated Plasmodium falciparum malaria.
Friday, 18 March 2022
Sharing expertise with scientific collaborators in India
Last year, the Indian Council for Medical Research (ICMR) National Institute of Malaria Research (NIMR) and IDDO began collaborating on a joint capacity building venture to train young researchers across three infectious diseases.
Monday, 28 February 2022
ANTICOV trial finds drug combination nitazoxanide + ciclesonide does not reduce risk of hospitalization in COVID-19 outpatients
KINSHASA / NAIROBI / GENEVA – 28 February 2022 – The ANTICOV platform clinical trial, launched in September 2020 in 13 African countries to identify treatments for mild and moderate cases of COVID-19, has stopped recruiting patients into one of its treatment arms, the drug combination nitazoxanide a...
Thursday, 10 February 2022
ANTICOV: clinical trial for COVID-19 in low-resource settings to test a new combination treatment, fluoxetine and budesonide
KINSHASA / NAIROBI / GENEVA – 8 February 2022 – The ANTICOV platform clinical trial has started the recruitment of participants to test a new promising drug combination, fluoxetine and budesonide, as an early treatment for people affected with mild-to-moderate COVID-19.
Friday, 19 November 2021
Paul Newton named ASTMH Distinguished International Fellow
Professor Paul Newton was announced new Distinguished International Fellow at the ASTMH Annual Meeting Awards Ceremony on the 17th November. This distinction formally recognises individuals who have made eminent contributions to a particular aspect of tropical medicine or hygiene.
Thursday, 28 October 2021
Large-scale systematic review identifies research gaps in scrub typhus
A new, extensive systematic review has identified significant research gaps in the treatment of scrub typhus which could be improved by developing a database for individual participant data (IPD) to enable more detailed analyses to address important knowledge gaps such as the optimum dosing for chil...